We therefore hypothesized that (a) the peri-infarct region shows alterations of ceramide levels, that (b) these alterations result from a change of ASM activity, and (c) that fluoxetine improves motor recovery after stroke, and this effect might be mediated by ASM inhibition. Here, SMPD1 is linked to Stroke.